1. Home
  2. IIIV vs CSTL Comparison

IIIV vs CSTL Comparison

Compare IIIV & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo i3 Verticals Inc.

IIIV

i3 Verticals Inc.

N/A

Current Price

$23.77

Market Cap

642.1M

Sector

Technology

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$26.85

Market Cap

806.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IIIV
CSTL
Founded
2012
2007
Country
United States
United States
Employees
N/A
883
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
642.1M
806.3M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
IIIV
CSTL
Price
$23.77
$26.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$33.20
$47.17
AVG Volume (30 Days)
392.0K
422.3K
Earning Date
05-06-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
N/A
$344,229,000.00
Revenue This Year
$9.05
$2.10
Revenue Next Year
$8.07
$12.63
P/E Ratio
$1,176.50
N/A
Revenue Growth
N/A
3.66
52 Week Low
$19.89
$14.59
52 Week High
$33.97
$44.28

Technical Indicators

Market Signals
Indicator
IIIV
CSTL
Relative Strength Index (RSI) 57.44 29.30
Support Level $22.51 $21.77
Resistance Level $27.02 $34.97
Average True Range (ATR) 0.81 1.68
MACD 0.32 -0.12
Stochastic Oscillator 87.65 13.48

Price Performance

Historical Comparison
IIIV
CSTL

About IIIV i3 Verticals Inc.

i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: